0001942327-22-000001.txt : 20220817
0001942327-22-000001.hdr.sgml : 20220817
20220817160859
ACCESSION NUMBER: 0001942327-22-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20220817
DATE AS OF CHANGE: 20220817
EFFECTIVENESS DATE: 20220817
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: GeneVentiv Therapeutics, Inc.
CENTRAL INDEX KEY: 0001942327
IRS NUMBER: 853580283
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-456181
FILM NUMBER: 221174101
BUSINESS ADDRESS:
STREET 1: 150 FAYETTEVILLE STREET
STREET 2: SUITE 2300
CITY: RALEIGH
STATE: NC
ZIP: 27601
BUSINESS PHONE: 919-529-3352
MAIL ADDRESS:
STREET 1: 150 FAYETTEVILLE STREET
STREET 2: SUITE 2300
CITY: RALEIGH
STATE: NC
ZIP: 27601
D
1
primary_doc.xml
X0708
D
LIVE
0001942327
GeneVentiv Therapeutics, Inc.
150 FAYETTEVILLE STREET
SUITE 2300
RALEIGH
NC
NORTH CAROLINA
27601
919-529-3352
DELAWARE
None
None
Corporation
true
2020
Damon
Race
150 FAYETTEVILLE STREET
SUITE 2300
RALEIGH
NC
NORTH CAROLINA
27601
Executive Officer
Director
Richard
Limehouse
150 FAYETTEVILLE STREET
SUITE 2300
RALEIGH
NC
NORTH CAROLINA
27601
Director
Biotechnology
Decline to Disclose
- 06b
false
2022-07-29
false
true
false
0
2000000
1399993
600007
false
1
0
0
0
None other than payments of salary in the ordinary course of business to certain of the parties named in response to Item 3.
false
GeneVentiv Therapeutics, Inc.
/s/ Damon R. Race
Damon R. Race
President and Chief Executive Officer
2022-08-17